Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay.
In developing countries, hepatitis E (HEV) and hepatitis A (HAV) are the major causes of acute viral hepatitis with similar feco-oral modes of transmission. In contrast to the high seroprevalence of hepatitis A infection, a low seroprevalence of HEV among children in endemic areas has been reported. These data suggest the possibility that silent HEV infection is undiagnosed by the current available methods. Many of the serological tests used for HEV diagnosis have poor specificity and are unable to differentiate among different genotypes of HEV. Moreover, the RT-PCR used for HEV isolation is only valid for a brief period during the acute stage of infection. Cell-mediated immune (CMI) responses are highly sensitive, and long lasting after sub-clinical infections as shown in HCV and HIV. Our objective was to develop a quantitative assay for cell-mediated immune (CMI) responses in HEV infection as a surrogate marker for HEV exposure in silent infection. Quantitative assessment of the CMI responses in HEV will also help us to evaluate the role of CMI in HEV morbidity. In this study, an HEV-specific interferon-gamma (IFN-gamma) ELISPOT assay was optimized to analyze HEV-specific CMI responses. We used peripheral blood mononuclear cells (PBMC) and sera from experimentally infected chimpanzees and from seroconverted and control human subjects to validate the assay. The HEV-specific IFN-gamma ELISPOT responses correlated strongly and significantly with anti-HEV ELISA positive/negative results (rho=0.73, p=0.02). Moreover, fine specificities of HEV-specific T cell responses could be identified using overlapping HEV ORF2 peptides.
Shata
M T
MT
Internal Medicine, Division of Digestive Diseases, University of Cincinnati, Cincinnati, OH 45267-0595, USA. mohamed.shata@uc.edu
Barrett
A
A
Shire
N J
NJ
Abdelwahab
S F
SF
Sobhy
M
M
Daef
E
E
El-Kamary
S S
SS
Hashem
M
M
Engle
R E
RE
Purcell
R H
RH
Emerson
S U
SU
Strickland
G T
GT
Sherman
K E
KE
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay; D016751:Hepatitis E / Q000097:blood / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*; D007118:Immunoassay; D016056:Immunodominant Epitopes; D007156:Immunologic Memory; D007371:Interferon-gamma / Q000032:analysis* / Q000276:immunology; D007963:Leukocytes, Mononuclear / Q000276:immunology* / Q000378:metabolism; D002679:Pan troglodytes
D000914:Antibodies, Viral; D016056:Immunodominant Epitopes; D007371:Interferon-gamma